MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

The latest financial statement is for the quarter ending 2025-09-30.

Cash Flow Overview

Free Cash flow
-$2,092K

Unit: Thousand (K) dollars (except for numbers of shares and EPS)
Cash Flow
2025-09-30
2025-06-30
Net loss
-2,392 -3,935
Depreciation and amortization
2 0
Amortization of right of use asset
0 0
Net gain/loss on disposal of property and equipment
0 0
Stock-based compensation
113 94
Prepaid expenses and other assets
269 165
Accounts payable
281 -18
Accrued expenses
180 209
Lease liability
0 0
Net cash used in operating activities
-2,085 -3,815
Cash paid for purchase of property and equipment
7 5
Net cash used in investing activities
-7 -5
Net proceeds from the exercise of warrants
200 2,720
Net proceeds from the issuance of common stock and warrants
8,345 6,493
Payments of taxes for net shares settled restricted stock unit issuances
30 0
Net cash provided by financing activities
2,022 9,213
Net decrease in cash, cash equivalents and restricted cash
5,323 -
Cash and cash equivalents at beginning of period
5,382 -
Net increase (decrease) in cash and cash equivalents
-5,393
Cash and cash equivalents at end of period
10,705 -
Unit: Thousand (K) dollars

Time Plot

Show the time plot by selecting a row from the table.

Phio Pharmaceuticals Corp. (PHIO)

Phio Pharmaceuticals Corp. (PHIO)